Related Experiment Video
Updated: Jan 9, 2026

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
Published on: October 11, 2018
CBKMR: A Copula-based Bayesian Kernel Machine Regression Framework for Optimal Marker Detection in Omics Data
Anirban Chakraborty1, Chloe Mattila1, Debashis Ghosh2
1Department of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.
None:
High-throughput bulk and single-cell omics technologies enable comprehensive molecular profiling, yet identifying compact, biologically interpretable marker sets that distinguish cell types, conditions, or disease states remains challenging. Standard pipelines rely on univariate differential expression tests, which ignore gene-gene dependencies and nonlinear effects, while multivariate machine-learning (ML) methods often lack principled feature selection and uncertainty quantification. The Bayesian kernel machine regression (BKMR) framework offers an appealing alternative because it (a) captures nonlinear gene-outcome relationships and higher-order interactions, and (b) enables automatic relevance determination (ARD) through sparsity-inducing priors. However, we show that the traditional latent Gaussian process (GP) formulation of BKMR is inadequate for discrete outcomes (e.g., cell-type labels), leading to biased inference and unstable variable selection. We propose a copula-based Bayesian kernel machine regression (CBKMR) model that uses outcome-appropriate discrete marginals while a Gaussian copula captures kernel-induced dependence across observations. To ensure scalability to modern single-cell datasets, we further introduce a nearest-neighbor GP-based variant, NNCBKMR, which reduces computational complexity from to nearly linear in . Simulation studies show that CBKMR more accurately captures nonlinear effects and yields stronger marker-selection performance than BKMR and top ensemble ML methods (e.g., random forests, XGBoost). Applications to multiple scRNA-seq datasets demonstrate that CBKMR identifies concise marker panels that align closely with expert-annotated gene signatures while providingposterior uncertainty for principled decision-making.
More Related Videos
Related Concept Videos
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation
On...
Cluster Sampling Method
To choose a cluster sample, divide the population into clusters (groups) and then randomly select some of the clusters. All the members from these clusters are in the cluster sample. For example, if you randomly sample four departments from your...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
Mechanistic Models: Compartment Models in Individual and Population Analysis

